CORONARY DRUG ELUTING STENTS

Description :SRPHC82281210-CORONARY DRUG ELUTING STENTS (1) SINGLE WIRE TECHNOLOGY ON COBALT BASED ALLOY PLATFORM (2) STENT WITH COATING OF BIOLINX POLYMER CARRIER FOR ACTIVE DRUG ZOTAROLIMUS SHOWN T O BE EFFECTIVE IN PREVENTING NEO-INTIMAL HYPERPLASIA) (3) STENT DIAMETER SHOULD BE FROM 2.25 MM TO 4 MM AND LENGTH OF THE STENT FROM 12MM TO 38 MM. (4) THE STRUT THICKNESS SHOULD BE 81 MICRON OR LESS. (5) S TENT DELIVERY SYSTEM SHOULD BE MONORAIL (SINGLE OPERATOR EXCHANGE OR RAPID EXCHANGE). (6) STENT SHO ULD BE COMPATIBLE WITH 5FR GUIDING CATHETER (7) STENT DESIGN SHOULD BE OPEN CELL TYPE. (8) STENT SHOULD BE APPROVED BY DCGI. THE COPY OF DCGI APPROVAL SHOULD BE ENCLOSED IN THE TENDER BID. (9) FIVE YEARS LON G TERM EFFICACY AND SAFETY OF THE STENT IN TERMS OF TARGET VESSEL REVASCULARISATION (TVR) AND IN-SITU T HROMBOSIS (IST) SHOULD BE DOCUMENTED / PUBLISHED IN PEER REVIEWED SCIENTIFIC JOURNALS.(10) THE DOCUME NTS PERTAINING TO THE EFFICACY AND SAFETY OF THE STENT SHOULD BE ENCLOSED FOR THE BRAND THAT IS OFFER ED IN THE TENDER BID (11) THE MANUFACTURER/SUPPLIER SHOULD SUBMIT PROOF OF SUPPLY OF THE STENT TO A MA JOR GOVERNMENT INSTITUTE. [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 lacs ] ] Consignee ACHD/Surg.Store/RH/PER, SR Tamil Nadu 114.00 Numbers